Session Information
2008 BIO International Convention
Click here to go to the previous page
Aiming for the Bull's-Eye: The Pursuit of Personalized, Targeted Therapeutics
Track : Bench to Products
Program Code: 840
Date: Thursday, June 19, 2008
Time: 8:30 AM to 10:00 AM  EST
Location: 28CD
CHAIR :
Edward Abrahams, PhD, Executive Director, Personalized Medicine Coalition
SPEAKER (S):
John Babich, PhD, President, CSO , Molecular Insight Pharmaceuticals, Inc
Nathan Lakey, President & CEO, Orion Genomics
Patrick Soon-Shiong, MD, Chairman and CEO , Abraxis BioScience, Inc
Description
"One size fits all doesn't work in medicine; two people who
take the same drug may have very different responses. A hot
focus of many biopharmaceutical companies is the pursuit of
more personalized and targeted therapeutics because of their
potential of being more efficacious and efficient drug candidates in individual patients with less risk of toxicity. How close are we to personalized medicine and who is leading the way?"

Objective 1:Review new challenges and advances in personalized medicine.

Objective 2:Highlight the companies working in this space.

Objective 3:"Educate on the promise of personalized therapeutics and how
these drugs will fit into the marketplace."



Streaming Audio with
PowerPoint Slides
(Code: 840)
  
This session is a part of: